Relationship between tumor markers CEA and CA15-3 and recurrence breast cancer
Hadi Rad Ghasabeh, S H Keyhanian
Abstract
Hadi Rad Ghasabeh, S H Keyhanian
Abstract
The value of clinical use of tumor markers CEA and CA15-3 for early detection of recurrent breast cancer still is a controversial. This study was investigated relationship between tumor markers CEA and CA15-3 and recurrence breast cancer. Data regarding 147 women who had breast cancer were entered into the study. Patients were reviewed for 120 months after treatment. Maximum time for relapse was considered a 6 months. Results were showed recurrence cancer in 20% of diagnosed patients. All of them in diagnosis time had a higher of normal tumor markers (CA<3, CA15-3<30).These observations indicated that CA15-3 is a sensitive tumor marker for diagnosis especially for recurrent breast cancer.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The value of clinical use of tumor markers CEA and CA15-3 for early detection of recurrent breast cancer still is a controversial. This study was investigated relationship between tumor markers CEA and CA15-3 and recurrence breast cancer. Data regarding 147 women who had breast cancer were entered into the study. Patients were reviewed for 120 months after treatment. Maximum time for relapse was considered a 6 months. Results were showed recurrence cancer in 20% of diagnosed patients. All of them in diagnosis time had a higher of normal tumor markers (CA<3, CA15-3<30).These observations indicated that CA15-3 is a sensitive tumor marker for diagnosis especially for recurrent breast cancer.
Key concepts: Breast cancer, Medicine, CA15-3, Oncology, CA 15-3, Cancer, Internal medicine, Recurrent breast cancer